Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries

Brigitte Michelsen* (Corresponding Author), Stylianos Georgiadis, Daniela Di Giuseppe, Anne G Loft, Michael J Nissen, Florenzo Iannone, Manuel Pombo-Suarez, Herman Mann, Ziga Rotar, Kari K Eklund, Tore K Kvien, Maria J Santos, Bjorn Gudbjornsson, Catalin Codreanu, Sema Yilmaz, Johan K Wallman, Cecilie H Brahe, Burkhard Möller, Ennio G Favalli, Carlos Sánchez-PiedraLucie Nekvindova, Matija Tomsic, Nina Trokovic, Eirik K Kristianslund, Helena Santos, Thorvardur J Löve, Ruxandra Ionescu, Yavuz Pehlivan, Gareth T Jones, Irene van der Horst-Bruinsma, Lykke M Ørnbjerg, Mikkel Østergaard, Merete L Hetland

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)
5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries'. Together they form a unique fingerprint.

Medicine & Life Sciences